Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Clinical measures. Kahn R. Diabetes Care. 1992 Aug;15(8):1081-3. PMID: 1505315
F-wave and M-response conduction velocity in diabetes mellitus. Argyropoulos CJ, Panayiotopoulos CP, Scarpalezos S, Nastas PE. Electromyogr Clin Neurophysiol. 1979 Sep-Oct;19(5):443-58. PMID: 527546
Assessment of gastric neuropathy using electrogastrography in asymptomatic diabetic patients. Correlation with cardiac autonomic neuropathy. Mayaudon H, Bauduceau B, Dupuy O, Cariou B, Ceccaldi B, Farret O, Molinie C. Diabetes Metab. 1999 Jun;25(2):138-42. PMID: 10443324
[Work accomplished by the Asociacion de Diabeticos del Uruguay]. GONZALEZ ALONSO R. Sem Med. 1963 Apr 15;122:624-7. PMID: 13963357
Diabetic neuropathy. HIRSON C, FEINMANN EL, WADE HJ. Br Med J. 1953 Jun 27;1(4825):1408-13. doi: 10.1136/bmj.1.4825.1408. PMID: 13042282
Status of research funded by the American Diabetes Association: year 2. Davidson MB. Diabetes Care. 2001 May;24(5):952. doi: 10.2337/diacare.24.5.952. PMID: 11347760
Diabetic neuropathies. Classification, clinical features, and pathophysiological basis. Sinnreich M, Taylor BV, Dyck PJ. Neurologist. 2005 Mar;11(2):63-79. doi: 10.1097/01.nrl.0000156314.24508.ed. PMID: 15733329
Follow-up study of sensory-motor polyneuropathy in type 1 (insulin-dependent) diabetic subjects after simultaneous pancreas and kidney transplantation and after graft rejection. Müller-Felber W, Landgraf R, Wagner S, Mair N, Nusser J, Landgraf-Leurs MM, Abendroth A, Illner WD, Land W. Diabetologia. 1991 Aug;34:S113-7. doi: 10.1007/BF00587634. PMID: 1936673
Pharmacological treatment of diabetic neuropathic pain. Smith HS, Argoff CE. Drugs. 2011 Mar 26;71(5):557-89. doi: 10.2165/11588940-000000000-00000. PMID: 21443281
Serum prolidase enzyme activity and oxidative stress levels in patients with diabetic neuropathy. Sayın R, Aslan M, Kucukoglu ME, Luleci A, Atmaca M, Esen R, Demir H. Endocrine. 2014 Sep;47(1):146-51. doi: 10.1007/s12020-013-0136-3. Epub 2013 Dec 18. PMID: 24347244
Peripheral neuropathy in Behçet disease: an electroneurophysiological study. Akbulut L, Gur G, Bodur H, Alli N, Borman P. Clin Rheumatol. 2007 Aug;26(8):1240-4. doi: 10.1007/s10067-006-0466-0. Epub 2006 Dec 06. PMID: 17149536
A questionnaire for determining prevalence of diabetes related foot disease (Q-DFD): construction and validation. Bergin SM, Brand CA, Colman PG, Campbell DA. J Foot Ankle Res. 2009 Nov 25;2:34. doi: 10.1186/1757-1146-2-34. PMID: 19939276
Serum prolidase activity and oxidative status in patients with diabetic neuropathy. Uzar E, Tamam Y, Evliyaoglu O, Tuzcu A, Beyaz C, Acar A, Aydın B, Tasdemir N. Neurol Sci. 2012 Aug;33(4):875-80. doi: 10.1007/s10072-011-0857-0. Epub 2011 Nov 27. PMID: 22120188
The management of diabetic neuropathy in CKD. Pop-Busui R, Roberts L, Pennathur S, Kretzler M, Brosius FC, Feldman EL. Am J Kidney Dis. 2010 Feb;55(2):365-85. doi: 10.1053/j.ajkd.2009.10.050. Epub 2009 Dec 30. PMID: 20042258
Effects of omalizumab therapy on peripheral nerve functions: short observational study. Yavuz GO, Yılgör A, Yavuz IH, Milanlıoğlu A, Çilingir V, Çağaç A, Ozturk M, Bilgili SG. Postepy Dermatol Alergol. 2019 Apr;36(2):211-216. doi: 10.5114/ada.2018.74834. Epub 2018 Apr 03. PMID: 31320856
The electroneurophysiological evaluation of rheumatoid arthritis patients. Güler-Uysal F, Sivri A. Clin Rheumatol. 1998;17(5):416-8. doi: 10.1007/BF01450907. PMID: 9805193
